InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: turks post# 12798

Tuesday, 01/23/2018 2:30:00 PM

Tuesday, January 23, 2018 2:30:00 PM

Post# of 16911
Yes, it would be ironic if Braeburn's flop actually ended up great for us long-term stockholders who have been complaining about them for years. With 100% of the rights again for an approved drug, Titan could negotiate a much better license deal. My instinct is that if they were to get probuphine back, along with 100% of Parkinsons and T3, they would test the market for a sale transaction before outlicensing it again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News